206 related articles for article (PubMed ID: 11235632)
1. Insulin sensitizers.
Das S
J Assoc Physicians India; 1997; Suppl 1():32-6. PubMed ID: 11235632
[No Abstract] [Full Text] [Related]
2. [Prandial glucose regulator for type 2 diabetic patients. Beta cells produce insulin according to need].
MMW Fortschr Med; 1999 Sep; 141(36):61. PubMed ID: 10904606
[No Abstract] [Full Text] [Related]
3. [Against insulin resistance. Insulin sensitizers].
Verspohl EJ; Weiland F
Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
[No Abstract] [Full Text] [Related]
4. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
Kuritzky L; Nelson SE
J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
[No Abstract] [Full Text] [Related]
5. [Biguanide derivatives in diabetes mellitus].
Blagosklonnaia IaV; Zalevskaia AG; Krasi'lnikova EI; Ostroukhova EN; Dani'lchenko AR
Sov Med; 1989; (4):116-9. PubMed ID: 2669159
[No Abstract] [Full Text] [Related]
6. Diabetes: controlling the insulin balance. The pharmacologic repertoire.
Flavin K; Haire-Joshu D
Am J Nurs; 1986 Nov; 86(11):1244-51. PubMed ID: 3535510
[No Abstract] [Full Text] [Related]
7. [Type 2 diabetes: explosive issues in routine care].
Aumiller J
MMW Fortschr Med; 2009 Oct; 151(42):20. PubMed ID: 19938775
[No Abstract] [Full Text] [Related]
8. [Pharmacotherapies for type 1 diabetes mellitus].
Maruyama T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():190-5. PubMed ID: 12386992
[No Abstract] [Full Text] [Related]
9. [Diabetes mellitus and platelet half-life].
Banfi L; Vecchi C; Galetti A; Giussani R; Guzzini F
Clin Ter; 1987 May; 121(4):305-10. PubMed ID: 2973867
[No Abstract] [Full Text] [Related]
10. [Novo Nordisk introduces a new basic insulin for marketing].
Krankenpfl J; 2004; 42(5-6):168-9. PubMed ID: 15527230
[No Abstract] [Full Text] [Related]
11. A promising horizon. New treatment choices for diabetes.
Leccese C
Adv Nurse Pract; 1997 Oct; 5(10):60-2. PubMed ID: 9459988
[No Abstract] [Full Text] [Related]
12. [Insulin sensitizers is now approved as monotherapy as well. Lowering blood pressure with added effects].
MMW Fortschr Med; 2003 Oct; 145(41):47. PubMed ID: 14655486
[No Abstract] [Full Text] [Related]
13. Insulin aspart: a review.
Owens D; Vora J
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
[TBL] [Abstract][Full Text] [Related]
14. Insulin therapy for type 2 diabetes.
Pergallo-Dittko V
Diabetes Self Manag; 2003; 20(5):17, 21, 23-4. PubMed ID: 14679948
[No Abstract] [Full Text] [Related]
15. Insulin resistance and beta-cell function--a clinical perspective.
Matthews DR
Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S28-33. PubMed ID: 11685826
[No Abstract] [Full Text] [Related]
16. [Insulin analogs and new antidiabetic agents. Prospects in diabetes therapy].
Gallwitz B; Schmidt WE
Internist (Berl); 1997 Jun; 38(6):617-24; discussion 624. PubMed ID: 9265011
[No Abstract] [Full Text] [Related]
17. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
Mathieu C
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
[TBL] [Abstract][Full Text] [Related]
18. The pathogenesis of insulin resistance in children: metabolic complications and the roles of diet, exercise and pharmacotherapy in the prevention of type 2 diabetes.
Artz E; Freemark M
Pediatr Endocrinol Rev; 2004 Mar; 1(3):296-309. PubMed ID: 16437023
[TBL] [Abstract][Full Text] [Related]
19. [Long-acting insulin analogs: progressing slowly].
Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
[TBL] [Abstract][Full Text] [Related]
20. Addressing insulin resistance in Type 1 diabetes.
Pang TT; Narendran P
Diabet Med; 2008 Sep; 25(9):1015-24. PubMed ID: 19183305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
